Regulatory & Clinical Notice

Clinical AI Disclaimer

Effective Date: July 21, 2026 | Provided by MIIMANSA AI PRIVATE LIMITED

1. Medical & Clinical Decision Disclaimer

The software applications, APIs, and clinical entity modeling tools provided by MIIMANSA AI PRIVATE LIMITED are intended solely to assist clinical trial protocol authoring, medical writing, pharmacovigilance coding, and data management workflows. MiimansaAI is not a medical device, does not provide medical advice, and is not designed to diagnose, treat, cure, or prevent any disease.

2. Human-in-the-Loop (HITL) Requirement

Natural Language Processing (NLP) models, despite high benchmark precision, may encounter ambiguous clinical syntax or non-standard abbreviations. All extracted entity spans, trait scores (Negation, Temporality, Certainty, Subject), and ontology code mappings (ICD-10, SNOMED CT, RxNorm, LOINC) must be reviewed and verified by qualified clinical reviewers before being relied upon for medical treatment, regulatory submissions, or trial eligibility decisions.

3. Limitation of Liability

MIIMANSA AI PRIVATE LIMITED, its directors, officers, and employees shall not be liable for any direct, indirect, incidental, or consequential damages resulting from clinical reliance placed on unverified automated NLP outputs without human review.

4. Company Information

Legal Entity Name: MIIMANSA AI PRIVATE LIMITED
CIN: U62011HR2023PTC114845 | PAN: AARCM2751N
Registered Office: D-152, THE BELAIRE, GOLF COURSE ROAD, SEC 54, DLF QE, Dlf Qe, Gurgaon-122002, Haryana, India
Contact Email: hello@miimansaai.com